Longboard Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group

Longboard Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group

Dow JonesJun 20 22:53

Express News | Longboard Pharmaceuticals Inc : Evercore ISI Raises Target Price to $57 From $44

BreakingsJun 20 21:26

Cantor Fitzgerald Reiterates Overweight on Longboard Pharmaceuticals, Maintains $60 Price Target

Cantor Fitzgerald analyst Josh Schimmer reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and maintains $60 price target.

BenzingaJun 20 21:12

Evercore ISI Raises Price Target on Longboard Pharmaceuticals to $57 From $44, Maintains Outperform Rating

Longboard Pharmaceuticals (LBPH) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $32 to $60.

MT NewswiresJun 20 19:18

Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities

Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities

Dow JonesJun 12 02:55

Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities

Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities

Dow JonesJun 12 02:55